alphaveASTRAZEN₹6,843.00

AstraZeneca Pharma India Limited

₹ CrorePeersSANOFICONR PGHL SANOFI SENORES INNOVACAP MOREPENLAB IOLCP FDCMcap ₹17,108 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	60.4	63.6	117.5	117.5
+ Capital Work-in-Progress	0.3	0.0	0.0	0.0
+ Investment Property	4.2	0.0	0.0	0.0
+ Goodwill	2.1	0.0	0.0	0.0
+ Other Intangibles	0.0	0.7	0.0	0.0
+ Non-current Investments	52.6	0.0	0.0	0.0
+ Long-term Loans	0.3	0.1	0.0	0.0
+ Other Non-current Financial Assets	2.5	8.0	13.4	13.4
Non-current Financial Assets	55.4	8.1	13.4	13.4
+ Deferred Tax Assets	21.2	41.6	37.8	37.8
+ Other Non-current Assets	1.7	61.8	80.5	80.5
Total Non-current Assets	145.3	175.8	249.2	249.2
Current Assets
+ Inventories	227.9	548.5	1,027.3	1,027.3
+ Trade Receivables	153.1	184.9	213.7	213.7
+ Cash & Cash Equivalents	505.6	536.1	447.7	447.7
+ Other Bank Balances	0.3	0.6	0.9	0.9
+ Short-term Loans	0.1	0.3	0.0	0.0
+ Other Current Financial Assets	27.9	15.8	8.7	8.7
Current Financial Assets	686.9	737.7	671.0	671.0
+ Other Current Assets	17.9	56.2	33.8	33.8
Total Current Assets	932.7	1,342.4	1,732.2	1,732.2
Total Assets	1,078.0	1,518.1	1,989.1	1,989.1
Equity
+ Equity Share Capital	5.0	5.0	5.0	5.0
+ Other Equity / Reserves	706.9	765.4	867.8	867.8
Equity — Owners of Parent	711.9	770.4	872.8	872.8
Total Equity	711.9	770.4	872.8	872.8
Liabilities
+ Other Non-current Financial Liab	0.0	29.5	96.8	96.8
Non-current Financial Liabilities	2.8	29.5	96.8	96.8
+ Provisions — Non-current	6.2	6.3	15.8	15.8
+ Other Non-current Liabilities	0.0	9.0	21.9	21.9
Non-current Liabilities	9.0	44.8	134.5	134.5
+ Trade Payables	198.3	456.3	782.7	782.7
+ Other Current Financial Liab	31.0	31.6	36.7	36.7
Current Financial Liabilities	229.3	487.9	819.4	819.4
+ Provisions — Current	43.4	106.5	55.9	55.9
+ Current Tax Liabilities	6.7	10.6	5.4	5.4
+ Other Current Liabilities	77.7	98.0	101.1	101.1
Current Liabilities	357.1	703.0	981.8	981.8
Total Liabilities	366.1	747.8	1,116.3	1,116.3
Total Equity & Liabilities	1,078.0	1,518.1	1,989.1	1,989.1
Assets — additional as-filed lines
+ Non-current Assets Held for Sale	—	0.0	7.7	7.7
Liabilities — additional as-filed lines
+ Trade Payables — Non-current	2.8	0.0	0.0	0.0
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	2.5	2.0	2.0
+ Dues to Other Creditors — Current	—	453.8	780.7	780.7

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.